Compare YieldMax MSTR Option Income Strategy ETF (MSTY) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
YieldMax MSTR Option Income Strategy ETF vs 22nd Century Group Inc — how do they compare? YieldMax MSTR Option Income Strategy ETF trades at $13.56, while 22nd Century Group Inc trades at $4.48 (market cap $1.49M). Which is the better fit depends on your goals.
| MSTY | XXII | |
|---|---|---|
Sector | Income / Options Overlay | Technology |
52-Week High | $108.80 | $1.07K |
52-Week Low | $11.55 | $3.90 |
Market Cap | — | $1.49M |
Enterprise Value | — | -$6.74M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MSTY trades at $13.12, up 2.34% today but remains in a bearish technical trend with significant price erosion over the past six months. The ETF generates weekly distributions but has experienced substantial capital depreciation, with a $10,000 investment in January 2026 declining to approximately $6,614 by July 2026. Technical indicators show bearish momentum with resistance at $14 and support at $12, while fundamental valuation metrics remain unavailable for analysis.
The outlook remains challenging as MSTY's covered-call strategy caps upside potential while exposing investors to full downside risk. Despite high distribution yields, the structural limitations and dependence on underlying MSTR volatility create significant investment risks. Investors face uncapped losses despite regular payouts, with media coverage highlighting concerns about the ETF's long-term sustainability.
XXII trades at $4.32, down 0.23% on the day, with neutral technical signals and bearish moving averages. The company shows significant financial challenges with negative profit margins (-65.76% net income margin) and declining revenue, though analyst sentiment remains positive with 75% buy ratings. Recent corporate actions include a 20:1 reverse stock split completed in June 2026, while expansion initiatives in California and New York aim to drive VLN brand growth.
The outlook remains speculative with high execution risk given persistent losses and negative ROE (-130.19%). Investment opportunity hinges on successful commercialization of reduced-nicotine products and FDA regulatory progress, but substantial financial deterioration and competitive pressures present significant downside risk for shareholders.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About YieldMax MSTR Option Income Strategy ETF
MSTY is an actively managed ETF that pursues a synthetic covered call strategy on MicroStrategy Incorporated (MSTR) stock. The fund primarily sells call options on MSTR and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the volatile, Bitcoin-correlated growth potential of MSTR while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on MSTY →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
